September 5, 2022

Human Horizons Officially Launches the Ultra-futuristic DIGITAL GT, HiPhi Z

SHANGHAI, Sept. 5, 2022 /PRNewswire/ — Industry leader in new mobility and intelligent driving, Human Horizons, has officially launched its second flagship vehicle, the ultra-futuristic digital GT, HiPhi Z. The high-tech and ultra-luxurious car is aimed at “forward-thinking creators”, combining the latest in technological innovation with all the comforts of a luxury vehicle under the new market segment of TECHLUXE®. The HiPhi Z was officially launched on August 26th and has started accepting orders.

Reservations for test-driving the HiPhi Z are also officially open for interested customers, with drives available from October 1st. The company has also stated that, users who choose to pre-order their HiPhi Z in 2022, will be able to receive additional benefits as a thank you for their continued support of the brand. Following the success of the HiPhi X, which was the first domestic product to break into the top sales position for luxury electric cars in China, the HiPhi Z targets ‘young’, independently minded contemporary creators who believe in pushing boundaries, and bravely pursuing the future. Price of the HiPhi Z starts between $88,000-91,000 and production of the HiPhi Z is expected to begin later in 2022.

Speaking at the official launch of the HiPhi Z, Ding Lei, Founder, CEO, and Chairman of HiPhi, said “At Human Horizons, we are obsessed with thinking about the future; it motivates us and steers us towards our goals. We believe that the future holds many incredible advances for humanity, and we want to support the growth of technology in a way that helps make life more enjoyable and convenient. The HiPhi range is a chance for us to bring a piece of the future into the modern world, raise the standards of the automobile industry, and create a completely unique driving experience.”

True to the futuristic vision, the HiPhi Z is aesthetically refined with a V-shaped front hood, as well as the world’s first wrap-around Star-Ring ISD light curtain on a passenger vehicle consisting of 5,051 individual LEDs which can interact with passengers, drivers, and the world around it. In addition, the exterior features active air grille shutters (AGS) which connect with the rear spoiler and wing to automatically adjust vehicle drag and reduce lift for improved overall performance. The finished product is a clean, sleek, and fluid design made available in 6 different customizable colors of Nephrite Grey, Quartz Grey, Pearl White, Khaki Green, Smokey Blue and New White that stand apart from rivals in both performance and style.

The HiPhi Z’s world-leading autonomous performance is supported the HiPhi Pilot System which enables assisted driving and parking, as well as smart summon using the smartphone app. The ADAS system is built around an NVIDIA Orin X chip + QNX Neutrino real-time operating system (RTOS) and utilizes 34 sensors and LiDAR technology to constantly scan the surrounding environment. In addition, the software ensures a high degree of safety with dual redundancy for the six major systems of computing, perception, communication, braking, steering, and power supply.

Following the success of the HiPhi X, which was the first domestic product to break into the top sales position for luxury electric cars in China, the HiPhi Z targets ‘young’, independently minded contemporary creators who believe in pushing boundaries, and bravely pursuing the future. Production of the HiPhi Z is expected to begin later in 2022.

The HiPhi Z will appear alongside the HiPhi X as Human Horizons’ dual flagship model, embodying the company’s focus of bringing futuristic cars to life with connected, intelligent, and advanced technology. Both models will serve as leaders in the development of China’s new energy market, popularizing HiPhi as a leading electric vehicle brand in the high-end luxury segment. With regards to Human Horizons’ broader goals, the HiPhi brand fits within the company’s ‘3-Smart’ strategic blueprint to support the development of smart cars, smart transportation, and smart cities, underpinning a smarter and more technologically sophisticated future.

About HiPhi

HiPhi is a premium brand created by Human Horizons and enhanced by its users. HiPhi X is an EV with a lightweight hybrid aluminum-steel construction and sustainable vegan leathers and recyclable materials which add to the sustainable nature of Human Horizons’ EV products. HiPhi Logo

About Human Horizons

Human Horizons is established for R&D in innovative and leading intelligent mobility technologies as well as the industrialization of future-oriented smart vehicles. Furthermore, Human Horizons builds smart transportation technologies and contributes to the development of smart cities, which will redefine human mobility.

Photo – https://mma.prnewswire.com/media/1891406/image_1.jpg
Photo – https://mma.prnewswire.com/media/1891407/image_2.jpg
Logo – https://mma.prnewswire.com/media/1213394/HiPhi_Logo.jpg

September 5, 2022

Tronsmart Launches T7 – New Flagship Outdoor Bluetooth Speaker

SHENZHEN, China, Sept. 5, 2022 /PRNewswire/ — Tronsmart launched T7 portable Bluetooth speaker, another powerful speaker that upgraded from Tronsmart T6.

Tronsmart T7 Portable Outdoor Bluetooth Speaker

People are always keen on various outdoor adventures with friends or families. Whether it’s wandering or going to the beach, there shall be a lot of time spent on outdoor activities absolutely. What about music? Perhaps bringing a portable wireless speaker for background music. But how about the outdoor gatherings? That’s why T7 is launching.

Tronsmart’s T-Series has upgraded its legendary T6 wireless Bluetooth speaker with the release of the T7. Featuring a beat-driven light show, Tronsmart T7 is the perfect match for outdoor plans. A customizable backlight, pulsing and shimmering with the beat of the music. Flare up the atmosphere whether hosting a party or having guests over.

When it comes to sound quality, it delivers all-round stereo sound with a powerful woofer combined with back-to-back twin tweeters. Featuring Tronsmart’s patented SoundPulse audio, it creates booming bass in a compact size.

To further their commitment to music quality, Tronsmart has released an application that allows users to personalize EQ modes with one tap. Flexibly choose EQ modes to cater to different music tastes. Furthermore, it could also be used to enjoy exceptional stereo sound with superior clarity in stereo pairing mode.

Inherited the cylindrical design from T6 series, T7 is convenient to use and transport as before. It’s now possible to go even further with Tronsmart T7 outdoor speaker. IPX7 rating allows traveling without worrying about rough weather on the way to adventures. Also, a long-lasting battery guarantees up to 12 hours of continuous music playback on a single charge. Whether cycling, hiking or camping, T7 can cover any adventure that life suffers with ease.

Even if there are many speakers that are more portable than the Tronsmart T7, it is still worth buying with stunning 360° surround sound and vibrant lighting modes. If fascinated, do not hesitate to find detailed information and early-bird discount on Tronsmart Official Store, and purchase the speaker from Amazon US, Amazon UK and Amazon ES.

Photo – https://mma.prnewswire.com/media/1890605/image_1.jpg

September 5, 2022

‫شركة ترونسمارت تطلق مكبر الصوت بلوتوث الخارجي الجديد T7

شنجن، الصين, 5 أيلول/سبتمبر 2022/PRNewswire/ — أطلقت شركة “ترونسمارت” Tronsmart مكبر الصوت بلوتوث T7 المحمول، وهو مكبر صوت قوي آخر يمثل ترقية من مكبر صوت ترونسمارت تي 6.

يحرص الناس دائمًا على القيام بمغامرات خارجية متنوعة مع الأصدقاء أو الأسرة. وسواء كنت تتجول أو ذاهبا إلى الشاطئ، سيكون هناك بالتأكيد الكثير من الوقت الذي تقضيه في الأنشطة الخارجية. ماذا عن الموسيقى؟ ربما إحضار مكبر صوت لاسلكي محمول للموسيقى الخلفية. لكن ماذا عن التجمعات في الهواء الطلق؟ هذا هو سبب إطلاق مكبر صوت تي 7.

عملت سلسلة ترونسمارت تي مكبر صوتها الأسطوري اللاسلكي T6 بإصادرها مكبر صوت تي 7. يتميز ترونسمارت تي 7 بعرض ضوئي على حركه الإيقاع، وهو الخيار الأمثل لخطط الأنشطة الخارجية. إضاءة خلفية قابلة للتخصيص، نابضة ومتلألئة مع إيقاع الموسيقى. أشعل الأجواء سواء كنت تستضيف حفلة أو تستقبل ضيوفا في منزلك.

عندما يتعلق الأمر بجودة الصوت، فإن هذا المكبر يوفر صوت استيريو شاملا مع مكبر صوت قوي مدمج مع مكبرات صوت مزدوجة متتالية. وإذ يتميز بصوت SoundPulse الحاصل على براءة الاختراع من ترونسمارت، يخلق هذا المكبر صوتًا جهيرًا ومضخما عبر جهار من الحجم الصغير.

لتعزيز التزامها بجودة الموسيقى، أصدرت ترونسمارت تطبيقًا يسمح للمستخدمين بتخصيص أوضاع EQ بنقرة واحدة. اختر أوضاع EQ بمرونة لتلبية أذواقك الموسيقية المختلفة. علاوة على ذلك، يمكن استخدام المكبر أيضًا للاستمتاع بصوت استيريو استثنائي مع وضوح فائق في وضع اقتران الاستيريو.

وإذ يرث التصميم الأسطواني من سلسلة تي 6، يعتبر مكبر تي 7 مناسبا للاستخدام والنقل كما كان من قبل. أصبح من الممكن الآن الذهاب أبعد مع مكبر الصوت الخارجي ترونسمارت تي 7. يسمح تصنيف IPX7 لك بالسفر دون القلق بشأن الطقس السيئ في الطريق إلى المغامرات. بالإضافة إلى ذلك، تضمن البطارية الطويلة العمر، ما يصل إلى 12 ساعة من تشغيل الموسيقى المتواصل بشحنة واحدة. وسواء كان النشاط هو ركوب الدراجة أو التنزه أو التخييم، يمكن لـ تي 7 تغطية أي مغامرة تعاني منها في حياتك بسهولة.

وحتى ولو كانت هناك العديد من أنواع مكبرات الصوت المحمولة أكثر من ترونسمارت تي 7، فإن هذا المكبر لا يزال جديرا بالشراء بسبب تمتعه بصوت محيطي مذهل بزاوية 360 درجة وأوضاع إضاءة نابضة بالحياة. إذا أقنعك هذا، فلا تتردد في العثور على معلومات مفصلة وخصم مبكر على متجر ترونسمارت الرسمي </2069><2087 ، وشراء مكبر الصوت من <2120 Amazon US ، Amazon UK و Amazon ES .

الصوت – https://mma.prnewswire.com/media/1890605/image_1.jpg

September 5, 2022

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tuya Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TUYA

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tuya Inc. (NYSE: TUYA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Tuya’s March 2021 initial public offering (the “IPO”) of the important October 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Tuya securities pursuant and/or traceable to the Registration Statement you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO Registration Statement featured false and/or misleading statements and/or failed to disclose that: (1) a material portion of Tuya’s China-based customers were engaged in the widespread and systematic manipulation of reviews and product offerings in violation of Amazon.com’s terms of use; (2) prior to the IPO, a consumer investigation and data breach had exposed an illicit fake review scheme being perpetrated by many of Tuya’s clients, among others, which included, among other things, the exposure of 13 million records of organized fake review scams linked to over 200,000 Amazon account profiles; (3) as a result, there was a substantial risk that a material portion of Tuya’s significant customers would be barred from using Amazon.com’s platform, negatively impacting Tuya’s business, revenue, earnings, and prospects; and (4) as such, the IPO’s Registration Statement’s representations regarding Tuya’s historical financial and operational metrics and purported market opportunities and expected growth did not accurately reflect the actual business, operations, financial results, and trajectory of Tuya at the time of the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

September 5, 2022

HGEN INVESTOR ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – HGEN

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Humanigen, Inc. (NASDAQ: HGEN) between May 28, 2021 and July 12, 2022, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2022.

SO WHAT: If you purchased Humanigen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Humanigen class action, go to https://rosenlegal.com/submit-form/?case_id=8376 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business operations and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) lenzilumab was less effective in treating hospitalized COVID-19 patients than defendants had represented; (2) as a result, the U.S. Food and Drug Administration (“FDA”) was unlikely to approve the lenzilumab Emergency Use Authorization (“EUA”) and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint; (3) accordingly, lenzilumab’s clinical and commercial prospects were overstated; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Humanigen class action, go to https://rosenlegal.com/submit-form/?case_id=8376 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

September 5, 2022

OM FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – OM

NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and June 13, 2022, both dates inclusive (the “Class Period”), of the important September 6, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Outset Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had “continuously made improvements and updates to Tablo over time since its original clearance” that required an additional 510(k) application; (2) as a result, Outset Medical could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) Outset Medical’s inability to conduct the human factors study subjected Outset Medical to the likelihood of the FDA imposing a “shipment hold” and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants’ positive statements about Outset Medical’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Outset Medical class action, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information: